2010 was a vintage year for virtual patients (VPs) with an almost continuous sequence of publications and presentations at the major conferences. Notable examples include AMEE and its subsidiary e-Learning Symposium, the 2nd International Conference on VPs, and a large number of keynote presentations in national and international e-Learning and educational conferences. The increase in international collaboration, coupled to a reduction in VP creation costs and simpler creation tools, has all contributed to this sharp increase in interest. VPs have finally become embedded in the curriculum: in problem-based learning; as core components of lectures, tutorials and seminars; as assessment tools. The medical education community can increasingly turn its attention to the ways in which VPs can be used with the greatest efficiency and pedagogic value. Meanwhile, where will technology next take the VP? It is now possible to consider the extension of the current, relatively lightweight, VP into a truly interactive patient simulation, moving towards the concept of an 'e-human' or 'digital avatar'. At that stage, the simulation may take on new capabilities, offering authentic patient management, clinical and communication skills training, and the potential capability to mimic the health or disease of any citizen.
Medical schools are integrating more technology into the training of health care practitioners. Electronic Virtual Patients (VPs) provide interactive simulations to facilitate learning. The time, cost and effort required to create robust VPs on an individual school basis are significant; sharing of VPs by medical schools allows for access to a broad range of VPs across a variety of disciplines with lower investment. When this digital content is shared with other schools and distributed widely, digital copyright issues come into play. Unless all intellectual property rights (IPRs) and plans of the authors regarding the VP are confirmed upfront, the ability of the school to share the VP may be inhibited. Schools should also identify under what licensing/sharing model they plan to distribute the VPs - how do you plan to share the VPs and what will allow users to do with the VPs in the context of IPRs? This article highlights the role of IPRs in VPs and discusses a case-study of a European Virtual Patient collaboration to demonstrate how IPRs were managed.
Abstract:Lot of Companies is involving in the activities of the Supply Chain that is will used for different functions like company process management and relation between the suppliers and customers agents. The decision-tree based approach is used to make learn and recognize the logical methods of a tree structure. A state-of-the-art supply chain management [8] gives the coding rules as well as the Logical rules features needed by the system. Each attribute is classified and tested during the layout analysis and Logical features are collected and compared to the company's synthetic data set. The Agent-Based Modeling method is employed in the study is the Improved Chi -squared Automatic Interaction Detection" (I-CHAID method). All the user needs are tested around 50 dataset attribute contents belonging to the SCM with I-CHAID method; this will be representing the lower error rate for determining the logical labels are less than 5%. And also the efficiency like precision, recall, error rate will calculate and explains in detail functioning of I-CHAID with respect to the company's supply chain management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.